Luyang Yao
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 3
- Cancer-related Molecular Pathways 2
- Cancer Cells and Metastasis 2
-
- Cell death mechanisms and regulation 2
- RNA modifications and cancer 2
- Ubiquitin and proteasome pathways 1
- Co-authors
- Jianxin Gu (3 shared papers)Jianhai Jiang (2 shared papers)Steven H. Lin (7 shared papers)George R. Blumenschein (3 shared papers)Daniel R. Gomez (3 shared papers)John V. Heymach (4 shared papers)Anne S. Tsao (3 shared papers)Zhou Zhang (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Translational Lung Cancer Research (2 papers)Clinical Cancer Research (1 paper)Molecular and Cellular Biochemistry (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Luyang Yao
11 papers receiving 118 citations
Peers
Comparison fields: 5 of 31
- Oncology 59
- Pulmonary and Respiratory Medicine 43
- Cancer Research 14
- Developmental Neuroscience 3
- Cell Biology 11
Countries citing papers authored by Luyang Yao
This map shows the geographic impact of Luyang Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luyang Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luyang Yao more than expected).
Fields of papers citing papers by Luyang Yao
This network shows the impact of papers produced by Luyang Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luyang Yao. The network helps show where Luyang Yao may publish in the future.
Co-authors
The 25 scholars most cited alongside Luyang Yao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 22 | |
| 2 | 2018 | 20 | |
| 3 | 2005 | 17 | |
| 4 | 2007 | 15 | |
| 5 | 2006 | 15 | |
| 6 | 2020 | 9 | |
| 7 | 2020 | 6 | |
| 8 | 2023 | 6 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 2 | |
| 11 | 2020 | 1 |
About Luyang Yao
Luyang Yao is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 11 papers that have together received 119 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cell death mechanisms and regulation (2 papers), Cancer-related Molecular Pathways (2 papers), Cancer Cells and Metastasis (2 papers), RNA modifications and cancer (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Oncology (59 citations), Pulmonary and Respiratory Medicine (43 citations), Cancer Research (14 citations), Developmental Neuroscience (3 citations) and Cell Biology (11 citations). Luyang Yao has collaborated with scholars based in United States and China. Frequent co-authors include Jianxin Gu, Jianhai Jiang, Steven H. Lin, George R. Blumenschein, Daniel R. Gomez, John V. Heymach, Anne S. Tsao, Zhou Zhang, Zhongxing Liao and Chen Chen. Their work appears in journals such as Journal of Clinical Oncology, Translational Lung Cancer Research, Clinical Cancer Research, Molecular and Cellular Biochemistry and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.